Immediate Impact

8 by Nobel laureates 21 from Science/Nature 55 standout
Sub-graph 1 of 24

Citing Papers

Lipogenesis inhibitors: therapeutic opportunities and challenges
2022 Standout
Targeting cancer metabolism in the era of precision oncology
2021 Standout
3 intermediate papers

Works of Michael E. Pape being referenced

Effects of a novel dual lipid synthesis inhibitor and its potential utility in treating dyslipidemia and metabolic syndrome
2004
A novel compound that elevates high density lipoprotein and activates the peroxisome proliferator activated receptor
1998
and 1 more

Author Peers

Author Last Decade Papers Cites
Michael E. Pape 346 97 294 136 24 699
M E Pape 420 95 321 149 18 752
Shahida Shafi 321 76 194 72 29 796
Alain Théophile Sané 272 45 316 117 27 727
David E. Haft 243 107 183 184 20 583
Wendy S. Rosebury 486 87 261 118 15 822
Tetsuya Kitamine 440 135 355 122 14 784
Ilir Mehmeti 353 44 277 108 25 755
Melissa J. Longacre 391 40 329 145 20 677
Claude Vieu 235 116 247 84 20 710
Shunxing Rong 287 92 201 85 14 631

All Works

Loading papers...

Rankless by CCL
2026